2011Medical Journal of the Chinese People's Armed Police ForcesRequires access

Bioequivalence of levofloxacin hydrochloride oral liquid in healthy volunteers

Xiaohui Di

Open publisher page 0 citations

Abstract

Objective To study the relative bioavailability of levofloxacin hydrochloride oral liquid and tablets in healthy volunteers. Methods In a randomized two- way crossover design,a single oral dose of 200mg levofloxacin hydrochloride oral liquid and tablets were given to 24 male healthy volunteers.The plasma levofloxacin concentration within 36 h after administration was determined by HPLC and parameters C_(max),T_(max),T_(1/2),AUC_((0-1)),AUC_((0-∞)) were obtained and analyzed by two- one side test.Results The C_(max) were(2.80±0.59) and(2.64±0.56)μg /ml,respectively;T_(max) were(0.66±0.18 ) and(0.82±0.34) h,respectively;T_(1/2) were (6.60±1.37)and(7.26±1.20) h,respectively;AUC_((0-t)) were(14.97±2.32)μg.h/ml和(15.04±2.32)μg·h/ml,AUC_((0-∞)) were(15.66±2.38 ) and(15.92±2.35 )μg.main pharmacokinetic parameters of levofloxacin hydrochloride oral liquid and tablets were as follows:C_(max) was(2.80±0.59) and(2.64±0.56)μg/ml,respectively;T_(max) was(0.66±0.18) and(0.82±0.34) h,respectively; T_(1/2) was(6.60±1.37) and(7.26±1.20) h,respectively;AUC_((0-t)) was(14.97±2.32)μg·h/ml and(15.04±2.32)μg·h/ml,respectively.AUC_((0-∞)) was(15.66±2.38) and(15.92±2.35)μg·h/ml,respectively.There was no statistically significant difference between these two test groups.The relative bioavailability of the test oral liquid was(100.1±10.6)%.Conclusions The levofloxacin hydrochloride oral liquid and tablets are bioequivalent.

About this research paper

What this paper is about

Objective To study the relative bioavailability of levofloxacin hydrochloride oral liquid and tablets in healthy volunteers. Methods In a randomized two- way crossover design,a single oral dose of 200mg levofloxacin hydrochloride oral liquid and tablets were given to 24 male healthy volunteers.The plasma levofloxacin concentration within 36 h after administration was determined by HPLC and parameters C_(max),T_(max),T_(1/2),AUC_((0-1)),AUC_((0-∞)) were obtained and analyzed by two- one side test.Results The C_(max) were(2.80±0.59) and(2.64±0.56)μg /ml,respectively;T_(max) were(0.66±0.18 ) and(0.82±0.34) h,respectively;T_(1/2) were (6.60±1.37)and(7.26±1.20) h,respectively;AUC_((0-t)) were(14.97±2.32)μg.h/ml和(15.04±2.32)μg·h/ml,AUC_((0-∞)) were(15.66±2.38 ) and(15.92±2.35 )μg.main pharmacokinetic parameters of levofloxacin hydrochloride oral liquid and tablets were as follows:C_(max) was(2.80±0.59) and(2.64±0.56)μg/ml,respectively;T_(max) was(0.66±0.18) and(0.82±0.34) h,respectively; T_(1/2) was(6.60±1.37) and(7.26±1.20) h,respectively;AUC_((0-t)) was(14.97±2.32)μg·h/ml and(15.04±2.32)μg·h/ml,respectively.AUC_((0-∞)) was(15.66±2.38) and(15.92±2.35)μg·h/ml,respectively.There was no statistically significant difference between these two test groups.The relative bioavailability of the test oral liquid was(100.1±10.6)%.Conclusions The levofloxacin hydrochloride oral liquid and tablets are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the relative bioavailability of levofloxacin hydrochloride oral liquid and tablets in healthy volunteers. Methods In a randomized two- way crossover design,a single oral dose of 200mg levofloxacin hydrochloride oral liquid and tablets were given to 24 male healthy volunteers.The plasma levofloxacin concentration within 36 h after administration was determined by HPLC and parameters C_(max),T_(max),T_(1/2),AUC_((0-1)),AUC_((0-∞)) were obtained and analyzed by two- one side test.Results The C_(max) were(2.80±0.59) and(2.64±0.56)μg /ml,respectively;T_(max) were(0.66±0.18 ) and(0.82±0.34) h,respectively;T_(1/2) were (6.60±1.37)and(7.26±1.20) h,respectively;AUC_((0-t)) were(14.97±2.32)μg.h/ml和(15.04±2.32)μg·h/ml,AUC_((0-∞)) were(15.66±2.38 ) and(15.92±2.35 )μg.main pharmacokinetic parameters of levofloxacin hydrochloride oral liquid and tablets were as follows:C_(max) was(2.80±0.59) and(2.64±0.56)μg/ml,respectively;T_(max) was(0.66±0.18) and(0.82±0.34) h,respectively; T_(1/2) was(6.60±1.37) and(7.26±1.20) h,respectively;AUC_((0-t)) was(14.97±2.32)μg·h/ml and(15.04±2.32)μg·h/ml,respectively.AUC_((0-∞)) was(15.66±2.38) and(15.92±2.35)μg·h/ml,respectively.There was no statistically significant difference between these two test groups.The relative bioavailability of the test oral liquid was(100.1±10.6)%.Conclusions The levofloxacin hydrochloride oral liquid and tablets are bioequivalent.

Key concepts: Bioequivalence, Levofloxacin, Bioavailability, Pharmacokinetics, High-performance liquid chromatography, Hydrochloride, Crossover study, Oral administration

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of levofloxacin hydrochloride oral liquid in healthy volunteers — Research Paper | ScholarLens